Careplus Group Berhad Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Careplus Group Berhad şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

-9.6%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-9.6%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	RM 0.040
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Recent updates

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Feb 07

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Dec 18

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Nov 23

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Sep 07

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Apr 01

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Feb 26

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Feb 13

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Jan 17

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Dec 13

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: CAREPLS şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: CAREPLS şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Careplus Group Berhad Piyasaya Karşı Temettü Getirisi

CAREPLS temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (CAREPLS)	0%
Pazarın Alt %25'i (MY)	1.9%
Pazarın En İyi %25'i (MY)	4.9%
Sektör Ortalaması (Medical Equipment)	1.5%
Analist tahmini (CAREPLS) (3 yıla kadar)	n/a

Önemli Temettü: CAREPLS şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, CAREPLS şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: CAREPLS MY piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: CAREPLS herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Careplus Group Berhad Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Upcoming dividend of RM0.02 per share

Upcoming dividend of RM0.02 per share

Careplus Group Berhad Declares Interim Dividend for the Financial Year Ending 31 December 2021, Payable on 16 June 2021

Recent updates

First quarter 2025 earnings released: RM0.01 loss per share (vs RM0.14 loss in 1Q 2024)

New minor risk - Share price stability

Careplus Group Berhad, Annual General Meeting, Dec 04, 2024

Insufficient new directors

Careplus Group Berhad has filed a Follow-on Equity Offering.

Full year 2024 earnings released: RM0.042 loss per share (vs RM0.26 loss in FY 2023)

Careplus Group Berhad Announces Appointment of A Ley Lim as Joint Secretary

Careplus Group Berhad announced that it expects to receive MYR 17.47356 million in funding

New minor risk - Financial data availability

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Careplus Group Berhad, Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New minor risk - Shareholder dilution

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New major risk - Revenue and earnings growth

Careplus Group Berhad Announces the Re-Designation of Puan Hazrena Binti Yahaya as Non-Independent Director from Independent Director

Careplus Group Berhad Announces Resignation of Madam Yew Yee Peng as Executive Director

Careplus Group Berhad Appoints Loo Hui Yan as Joint Secretary

Full year 2022 earnings released

Ansell Services (Asia) Sdn. Bhd. agreed to acquire 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS) for MYR 37.5 million.

Careplus Group Berhad announced that it expects to receive MYR 49.8 million in funding

Careplus Group Berhad Announces Redesignation of Yee Chow Boi from Member of Remuneration Committee to Independent and Non Executive Chairman of Remuneration Committee

Now 21% undervalued

Third quarter 2022 earnings released: RM0.053 loss per share (vs RM0.015 profit in 3Q 2021)

Insufficient new directors

Careplus Group Berhad Announces Material Litigation Update

Second quarter 2022 earnings released: RM0.062 loss per share (vs RM0.20 profit in 2Q 2021)

First quarter 2022 earnings released: RM0.066 loss per share (vs RM0.23 profit in 1Q 2021)

Careplus Group Berhad, Annual General Meeting, Jun 08, 2022

Insufficient new directors

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?

Insufficient new directors

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Second quarter 2021 earnings released: EPS RM0.20 (vs RM0.067 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Careplus Group Berhad Declares Interim Dividend for the Financial Year Ending 31 December 2021, Payable on 16 June 2021

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS RM0.23 (vs RM0.011 loss in FY 2019)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Full year 2020 earnings released

New 90-day low: RM1.94

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Investor sentiment deteriorated over the past week

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Investor sentiment improved over the past week

New 90-day low: RM2.07

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: RM2.34

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Careplus Group Berhad (KLSE:CAREPLS) and Tang Kin San completed the acquisition of Centro Heights Sdn. Bhd. from Chang Keng Chiang, Chang Sze Wei and Chang Kai Ping.

Market pulls back on stock over the past week

Market pulls back on stock over the past week